Long-term glucocorticoid treatment in patients with polymyalgia rheumatica: can we just move a step forward? Comments on "Long-term glucocorticoid treatment and high relapse rate remain unresolved issues in the real-life management of polymyalgia rheumatica: a systematic literature review and meta-analysis"

Ciro Manzo^{1

2}

Affiliations

¹ Internal and Geriatric Medicine department, Rheumatologic Outpatient Clinic Health District No. 59, Azienda Sanitaria Locale Napoli 3 sud, Sant'Agnello (Naples), viale dei Pini, 1, Naples, Italy. manzoreumatologo@libero.it.
² Poliambulatorio "Mariano Lauro", Viale Dei Pini 1, 80065, Sant'Agnello, Italy. manzoreumatologo@libero.it.

Comment

Ciro Manzo. Clin Rheumatol. 2021 Oct.

. 2021 Oct;40(10):4367-4368.

doi: 10.1007/s10067-021-05898-y. Epub 2021 Aug 30.

Ciro Manzo^{1

2}

¹ Internal and Geriatric Medicine department, Rheumatologic Outpatient Clinic Health District No. 59, Azienda Sanitaria Locale Napoli 3 sud, Sant'Agnello (Naples), viale dei Pini, 1, Naples, Italy. manzoreumatologo@libero.it.
² Poliambulatorio "Mariano Lauro", Viale Dei Pini 1, 80065, Sant'Agnello, Italy. manzoreumatologo@libero.it.

No abstract available

Comment on

Long-term glucocorticoid treatment and high relapse rate remain unresolved issues in the real-life management of polymyalgia rheumatica: a systematic literature review and meta-analysis.
Floris A, Piga M, Chessa E, Congia M, Erre GL, Angioni MM, Mathieu A, Cauli A. Floris A, et al. Clin Rheumatol. 2022 Jan;41(1):19-31. doi: 10.1007/s10067-021-05819-z. Epub 2021 Aug 20. Clin Rheumatol. 2022. PMID: 34415462 Free PMC article.

1. Floris A, Piga M, Chessa E et al (2021) Long-term glucocorticoid treatment and high relapse rate remain unresolved issues in the real-life management of polymyalgia rheumatica: a systematic literature review and meta-analysis. Clin Rheumatol. https://doi.org/10.1007/s10067-021-05819-z - DOI - PubMed
1. Manzo C, Milchert M, Natale M, Brzosko M (2019) Polymyalgia rheumatica with normal values of both erythrocyte sedimentation rate and C-reactive protein concentration at the time of diagnosis. Rheumatology (Oxford) 58:921–923. https://doi.org/10.1093/rheumatology/key431 - DOI
1. Marsman DE, Den Broeder N, Boers N et al (2021) Polymyalgia rheumatica patients with and without elevated baseline acute phase reactants: distinct subgroups of polymyalgia rheumatica? Clin Exp Rheumatol 39:32–37 - PubMed
1. Manzo C (2021) C-reactive protein concentrations as predictors of glucocorticoid-free remission in patients with polymyalgia rheumatica. Int J Rheum Dis 24:284–285. https://doi.org/10.1111/1756-185X.14054 - DOI - PubMed
1. Cimmino MA, Parodi M, Montecucco C, Caporali R (2011) The correct prednisone starting dose in polymyalgia rheumatica is related to body weight but not to disease severity. BMC Musculoskelet Disord 12:94. https://doi.org/10.1186/1471-2474-12-94 - DOI - PubMed - PMC